|
Sign In to gain access to subscriptions and/or personal tools.
|
Effects of telmisartan on arterial stiffness in Type 2 diabetes patients with essential hypertension
Roland Asmar
The Cardiovascular Institute, Paris, France, ra{at}icv.org
Phillipe Gosse
Hôpital St André, Bordeaux, France
Jirar Topouchian
The Cardiovascular Institute, Paris, France
Gilbert N'tela
Hôpital St André, Bordeaux, France
Amanda Dudley
GlaxoSmithKline, Greenford, UK
Gillian L Shepherd
GlaxoSmithKline, Greenford, UK
Arterial wall stiffness, an important independent risk factor for cardiovascular disease in patients with hypertension, is worsened by the coexistence of diabetes mellitus. This randomised, prospective, double-blind, crossover trial assessed the effects of telmisartan on arterial stiffness in patients with Type 2 diabetes with essential hypertension. After a two-week placebo wash out period, 28 ambulatory patients received telmisartan (40 mg) or placebo for three weeks. Following a second two-week placebo wash out period, patients received the alternate treatment for a further three weeks. Augmentation index and central blood pressure (BP) were determined using the SphygmoCorTM device and pulse wave velocity (PWV) was measured using an automatic device, the CompliorTM, at the beginning and the end of each period. Telmisartan significantly reduced the carotid—femoral PWV compared with placebo (mean adjusted treatment difference —0.95 m/s; 95% CI: —1.67, —0.23 m/s; p=0.013). Peripheral and central diastolic, systolic and pulse pressures were also significantly reduced with telmisartan compared with placebo. In conclusion, telmisartan reduces arterial stiffness and peripheral and central BPs as assessed by PWV and pulse contour analysis in hypertensive patients with Type 2 diabetes. These properties of telmisartan suggest that it may improve cardiovascular outcome in this patient population.
Key Words: telmisartan • diabetes • hypertension • pulse wave velocity • stiffness • blood pressure • angiotensin II receptor blocker • pulse pressure
References
- King P., Peacock I., Donnelly R. The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for Type 2 diabetes. BrJClin Pharmacol 1999;48:643-8.
- Joint National Committee on Prevention, Detection, Evaluation,Treatment of High Blood Pressure.The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46.[Abstract/Free Full Text]
- Laurent S., Boutouyrie P., Asmar R. et al.Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001;37:1236-41.[Abstract/Free Full Text]
- Asmar R. Arterial Stiffness and Pulse Wave Velocity. In: Pulse wave velocity and prognosis. Paris: Elsevier; 1999; 93-9.
- O'Rourke MF Arterial mechanics and wave reflection with antihypertensive therapy. J Hypertens 1992;10(suppl 5):S43-9.
- O'Rourke MF, Gallagher DE Pulse wave analysis. J Hypertens 1996;14(suppl 5):S147-57.[CrossRef][Web of Science]
- O'Rourke MF, Kelly RP, Avolio AP, Hayward C. Effects of arterial dilator agents on central aortic systolic pressure and on left ventricular hydraulic load. Am J Cardiol 1989;63:381-441.
- Safar ME Pulse pressure in essential hypertension: clinical and therapeutical implications. J Hypertens 1989;7:769-76.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Chen CH,Ting C-T., Lin S-J. et al. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension 1995;25:1034-41.[Abstract/Free Full Text]
- BenetosA, Levy BI, Lacolley P.,Taillard F., Duriez M., Safar ME Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats. ArteriosclerThromb Vasc Biol 1997;17:3196-201.[Abstract/Free Full Text]
- Neutel JM, Smith DHG. Dose response and antihypertensive efficacy of the AT1 receptor antagonist telmisartan in patients with mild to moderate hypertension. Adv Ther 1998;15:206-17.[Web of Science]
- Smith DHG, Neutel JM, Morgenstern P. Once-daily telmisartan compared with enalapril in the treatment of hypertension. Adv Ther 1998;15:229-40.[Web of Science]
- Lacourcière Y., Lenis J., Orchard R. et al.A comparison of the efficacy and duration of action of the angiotensin II receptor blocker telmisartan to amlodipine. Blood Press Monit 1998;3:295-302.[Medline]
[Order article via Infotrieve]
- Neutel JM, Frishman WH, Oparil S., Papademitriou V., Guthrie G. Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension. Am J Ther 1999;6:161-6.[Medline]
[Order article via Infotrieve]
- Mallion JM, Siché JP, Lacourcière Y., the Telmisartan Blood Pressure Monitoring Group. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension. J Hum Hypertens 1999;13:657-64.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lacourcière Y., the Telmisartan Cough Study Group. The incidence of cough: a comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist. Int J Clin Pract 1999;53:99-103.[Web of Science][Medline]
[Order article via Infotrieve]
- Karlberg BE, Lins L.-E, Hermansson K., for the TEES Study Group. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. J Hypertens 1999;17:293-302.[Web of Science][Medline]
[Order article via Infotrieve]
- Sharpe M., Jarvis B., Goa KL Telmisartan: a review of its use in hypertension. Drugs 2001;61:1501-29.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Asmar R.,Topouchian J.,Pannier B., BenetosA., Safar M. Pulse wave velocity as endpoint in large-scale intervention trial. The Complior study. Scientific, Quality Control, Coordination and Investigation Committees of the Complior Study. J Hypertens 2001;19:813-18.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Nichols WW, O'Rourke MF (eds.). MacDonald's blood flow in arteries. Theoretical, experimental and clinical principals. 4th ed. London: Edward Arnold, 1998;54-113, 201-22, 8492,347-401.
- Avolio AP, Chen SG, Wang RP, Zhang CL, Li MF, O'Rourke MF Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation 1983;68:50-8.[Abstract/Free Full Text]
- Asmar R., BenetosA, London G. et al.Aortic distensibility in normotensive, untreated and treated hypertensive patients. Blood Press 1995;4:48-54.[Medline]
[Order article via Infotrieve]
- Lehmann ED, Gosling RG, Sonksen PH Arterial wall compliance in diabetes. Diabet Med 1992;9:114-19.[Web of Science][Medline]
[Order article via Infotrieve]
- Glasser SP, Arnett DK, McVeigh GE et al. Vascular compliance and cardiovascular disease: a risk factor or a marker? Am J Hypertens 1997;10:1175-89.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Brooks B., Molyneaux L., Yue DK Augmentation of central arterial pressure in Type 1 diabetes. Diabetes Care 1999;22:1722-7.[Abstract/Free Full Text]
- Gosse P., Jullien V., Jarnier P., Lemetayer P., Clementy J. Reduction in arterial distensibility in hypertensive patients as evaluated by ambulatory measurement of the QKD interval is correlated with concentric remodeling of the left ventricle. Am J Hypertens 1999;12:1252-5.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Wilkinson IB, MacCallum H., Rooijmans DF et al. Increased augmentation index and systolic stress in Type 1 diabetes mellitus. QJM 2000;93:441-8.[Abstract/Free Full Text]
- BenetosA, Laurent S.,Asmar RG, Lacolley P. Large artery stiffness in hypertension. J Hypertens 1997;15(suppl 2):S89-97.[Web of Science]
- Benetos A., Safar M., Rudnichi A. et al. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population.Hypertension 1997;30:1410-15.[Abstract/Free Full Text]
- Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study. Circulation 1999;100:354-60.[Abstract/Free Full Text]
- Madhavan S., Ooi WL, Cohen H., Alderman MH Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction.Hypertension 1994;23:395-401.[Abstract/Free Full Text]
- Blacher J., Staessen JA, Girerd X. et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000;160:1085-9.[Abstract/Free Full Text]
- Franklin SS Ageing and hypertension: the assessment of blood pressure indices in predicting coronary heart disease. J Hypertens 1999;17(suppl 5):S29-36.
- Blacher J.,Asmar R., Djane S., London GM, Safar ME Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients.Hypertension 1999;33:1111-17.[Abstract/Free Full Text]
- Collins R., MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994;50:272-98.[Abstract/Free Full Text]
- Hansson L., Zanchetti A., Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755-62.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Karamanoglu M., O'Rourke MF, Avolio AP, Kelly RP An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J 1993; 14:160-7.[Abstract/Free Full Text]
- Franklin SS New interpretations of blood pressure: the importance of pulse pressure. In: Oparil S, Weber MA (eds.). Hypertension: a companion to Brenner and Rector's The Kidney. Philadelphia: W.B. Saunders Company, 2000;227-34.
- DartAM, Reid CM, McGrath B., on behalf of the Tonometry Study Group. Effects of ACE inhibitor therapy on derived central arterial waveforms in hypertension. Am J Hypertens 2001;14:804-10.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Pannier BM, Guerin AP, Marchais SJ, London GM Different aortic reflection wave responses following long-term Angiotensin-converting enzyme inhibition and Beta-blocker in essential hypertension. Clin Exp Pharmacol Physiol 2001;28:1074-7.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Asmar RG, London GM, O'Rourke ME, Safar ME, and the REASON Project Coordinators and Investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension 2001;38:922-6.[Abstract/Free Full Text]
- Mahmud A., Feely J. Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension. J Hum Hypertens 2000;14:541-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 3, No. 3,
176-180 (2002)
DOI: 10.3317/jraas.2002.038
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
A. R. Khoshdel, S. L. Carney, B. R. Nair, and A. Gillies
Better Management of Cardiovascular Diseases by Pulse Wave Velocity: Combining Clinical Practice with Clinical Research using Evidence-Based Medicine
Clin. Med. Res.,
March 1, 2007;
5(1):
45 - 52.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. H. Dao, R. Essalihi, C. Bouvet, and P. Moreau
Evolution and modulation of age-related medial elastocalcinosis: Impact on large artery stiffness and isolated systolic hypertension
Cardiovasc Res,
May 1, 2005;
66(2):
307 - 317.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
